norfloxacin has been researched along with Liver Steatosis in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colle, I | 1 |
| De Keukeleire, K | 1 |
| Pauwels, W | 1 |
| Van Vlierberghe, H | 1 |
| Soza, A | 1 |
| Riquelme, A | 1 |
| González, R | 1 |
| Alvarez, M | 1 |
| Pérez-Ayuso, RM | 1 |
| Glasinovic, JC | 1 |
| Arrese, M | 1 |
2 other studies available for norfloxacin and Liver Steatosis
| Article | Year |
|---|---|
'Hepatic' encephalopathy because of spontaneous mesenterico-caval shunt.
Topics: Anti-Bacterial Agents; Collateral Circulation; Fatty Liver; Female; Gastrointestinal Agents; Hepatic | 2008 |
Increased orocecal transit time in patients with nonalcoholic fatty liver disease.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Breath Tests; Fatty Liver; Female; Gastrointesti | 2005 |